Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome
NCT00033293Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Mar 2004
- Primary completion
- Dec 2013
- Modality
- Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of NPB-01-ME in Opsoclonus-myoclonus-ataxia syndrome (OMS), sponsored by Children's Oncology Group. Started Mar 2004; status: completed.
02
Drugs
NPB-01-ME
03
Conditions
Opsoclonus-myoclonus-ataxia syndrome (OMS)
Beyond the preview
Go deeper on NCT00033293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033293.